• Capsazepine: A Better Pain Assay Strategy

  2026-08-31

  Capsazepine is a TRPV1 ion channel antagonist whose value extends beyond simple capsaicin blockade. This guide presents an orthogonal assay strategy that separates TRPV1 biology from calcium-current, TRPM8, and apoptosis-related effects.

• Polyethylenimine Linear in Translational Biology

  2026-08-31

  A mechanistic and strategic guide to using Polyethylenimine Linear (PEI), MW 40,000 for transient gene expression, HEK-293 transfection, and disease-model development inspired by emerging evidence on H3K18 lactylation, NOD2, and astrocyte pyroptosis.

• Macromolecular Cryoprotection for Assay-Ready THP-1 Cells

  2026-08-30

  A 2025 RSC Applied Polymers study shows that polyampholyte cryoprotectants and controlled ice nucleation can improve post-thaw recovery and differentiation of THP-1 monocytes in both vials and multi-well plates. By linking cryo-Raman evidence of reduced intracellular ice with functional macrophage readouts, the work advances the prospect of assay-ready immune-cell banking.

• Tetramethylrhodamine Ethyl Ester Perchlorate Guide

  2026-08-29

  Use Tetramethylrhodamine ethyl ester perchlorate to convert mitochondrial membrane potential into a live-cell fluorescence readout for microscopy, flow cytometry, and plate-based assays. Its greatest value is functional: it complements ROS, apoptosis, and protein-level measurements by showing whether mitochondria remain electrically polarized during injury or recovery.

• Angiotensin I/II (1-5): Practical RAS Guide

  2026-08-28

  Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for controlled renin-angiotensin system research involving blood pressure regulation and aldosterone signaling. It is suited to cardiovascular and renal workflows with validated peptide handling, but should not be extended to unrelated signaling assays or used to infer potency values not provided in the product dossier.

• CDK9 inhibitor (A3294): Protocol and QC Guide

  2026-08-28

  CDK9 inhibitor (A3294) is a selective serine/threonine kinase inhibitor for studying CDK9-dependent transcription elongation and HIV-1 propagation in defined experimental systems. It is suitable for CDK9-focused biochemical, cellular, and MT4 assay workflows, but not for broad CDK inhibition, generalized antiviral claims, or long-term storage of prepared solutions.

• Cimetidine at the GI–BBB Translational Interface

  2026-08-27

  Cimetidine offers translational researchers a distinctive H2R pharmacology for connecting gastric acid biology, gastrointestinal cancer research, and disciplined blood–brain barrier testing. This article outlines mechanistic questions, assay parameters, competitive considerations, and practical strategies for evaluating its context-dependent activity without overstating the evidence.

• Extracellular Vesicles in Hyperoxia-Induced BPD

  2026-08-27

  This study identifies fibroblast-derived extracellular vesicles as active regulators of alveolar epithelial mitochondrial quality control during moderate hyperoxia. Its findings connect VDAC1–GCN2 signaling, impaired BNIP3-dependent mitophagy, and alveolar developmental arrest, while suggesting that EV release or replacement may be experimentally tractable intervention points in bronchopulmonary dysplasia.

• Saracatinib (AZD0530): Src Signaling Assay Logic

  2026-08-26

  Saracatinib (AZD0530) is a potent Src/Abl inhibitor for resolving kinase-dependent phenotypes in cancer biology and synaptic signaling research. This article connects biochemical potency with assay design, pathway interpretation, and the translational limits of cross-domain inference.

• Angiotensin II: Sex-Aware Experimental Design

  2026-08-26

  Angiotensin II research is more informative when exposure, sex, autonomic control, and vascular phenotype are analyzed together. This guide translates landmark telemetry findings into practical decisions for hypertension, remodeling, and vascular-cell assays.

• Proteinase K for Translational Proteomics and DNA Prep

  2026-08-25

  Proteinase K is more than a routine digestion reagent. Its broad substrate scope, compatibility with challenging buffers, and utility in protease-protection experiments make it a strategic tool for genomic DNA isolation, enzyme contaminant removal for DNA prep, and mechanistic extracellular-vesicle research.

• TP53 Shapes Calicheamicin ADC Response in Acute Leukemia

  2026-08-25

  A genome-wide CRISPR/Cas9 screen identifies TP53, ATM, and MDM2 as major regulators of calicheamicin sensitivity in acute leukemia models. The findings distinguish DNA damage response dependencies that can enhance antibody–drug conjugate activity from PARP inhibition, which showed no broad sensitizing effect in the tested panel.

• SAR131675: VEGFR-3 Inhibitor Workflow Guide

  2026-08-24

  Use SAR131675 to separate VEGFR-3-dependent lymphatic signaling from broader endothelial phenotypes in biochemical, cellular, and tumor-model workflows. Its strong selectivity and nanomolar functional activity support mechanism-focused experiments, while its insolubility and discontinued development require disciplined formulation and interpretation.

• HOBt for High-Fidelity Amide Bond Formation

  2026-08-24

  HOBt supports controlled amide bond formation when stereochemical fidelity and mild reaction conditions matter. This guide translates its use from peptide synthesis into medicinal-chemistry workflows, including the indazole-based glucagon receptor antagonist series reported by Lin and colleagues.

• MPC, Lactate, and Histone Lactylation in CRC

  2026-08-23

  The reference study identifies a metabolic–epigenetic–immune pathway in colorectal cancer in which reduced MPC1/MPC2 activity increases lactate, elevates histone lactylation in dendritic cells, and weakens CD8+ T-cell responses. Its findings position MPC as a potential regulator of tumor progression and anti-PD-1 efficacy, while also providing a framework for studying lactate-dependent immune regulation.

7897 records 1/527 page Next 12345 下5页 Last page